Vincerx Pharma Net Worth
Vincerx Pharma Net Worth Breakdown | VINC |
Vincerx Pharma Net Worth Analysis
Vincerx Pharma's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Vincerx Pharma's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Vincerx Pharma's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Vincerx Pharma's net worth analysis. One common approach is to calculate Vincerx Pharma's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Vincerx Pharma's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Vincerx Pharma's net worth. This approach calculates the present value of Vincerx Pharma's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Vincerx Pharma's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Vincerx Pharma's net worth. This involves comparing Vincerx Pharma's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Vincerx Pharma's net worth relative to its peers.
Enterprise Value |
|
To determine if Vincerx Pharma is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Vincerx Pharma's net worth research are outlined below:
| Vincerx Pharma generated a negative expected return over the last 90 days | |
| Vincerx Pharma has high historical volatility and very poor performance | |
| Vincerx Pharma has some characteristics of a very speculative penny stock | |
| Vincerx Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (40.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vincerx Pharma currently holds about 80.86 M in cash with (40.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Vincerx Pharma has a poor financial position based on the latest SEC disclosures | |
| Roughly 18.0% of the company outstanding shares are owned by insiders | |
| Latest headline from gurufocus.com: Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI |
Vincerx Pharma uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Vincerx Pharma. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vincerx Pharma's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Vincerx Pharma's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Vincerx Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vincerx Pharma backward and forwards among themselves. Vincerx Pharma's institutional investor refers to the entity that pools money to purchase Vincerx Pharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Susquehanna International Group, Llp | 2024-12-31 | 21.4 K | Jane Street Group Llc | 2024-12-31 | 11.2 K | The Colony Group Llc | 2024-12-31 | 10.9 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.1 K | Bank & Trust Co | 2024-12-31 | 1000 | Sbi Securities Co Ltd | 2024-12-31 | 1000 | Bank Of America Corp | 2024-12-31 | 237 | Jpmorgan Chase & Co | 2024-12-31 | 23.0 | Goldman Sachs Group Inc | 2024-12-31 | 0.0 | Sage Rhino Capital Llc | 2024-12-31 | 1.7 M | Rock Springs Capital Management Lp | 2024-12-31 | 891.7 K |
Follow Vincerx Pharma's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.48 M.Market Cap |
|
Project Vincerx Pharma's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.54) | (2.41) | |
| Return On Capital Employed | (3.89) | (3.69) | |
| Return On Assets | (2.54) | (2.41) | |
| Return On Equity | (4.12) | (3.91) |
When accessing Vincerx Pharma's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Vincerx Pharma's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Vincerx Pharma's profitability and make more informed investment decisions.
Please note, the presentation of Vincerx Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vincerx Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vincerx Pharma's management manipulating its earnings.
Evaluate Vincerx Pharma's management efficiency
Vincerx Pharma has return on total asset (ROA) of (0.6599) % which means that it has lost $0.6599 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4245) %, meaning that it created substantial loss on money invested by shareholders. Vincerx Pharma's management efficiency ratios could be used to measure how well Vincerx Pharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.41. The current year's Return On Capital Employed is expected to grow to -3.69. At present, Vincerx Pharma's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.13, whereas Total Assets are forecasted to decline to about 19.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.61 | 0.58 | |
| Tangible Book Value Per Share | 0.61 | 0.58 | |
| Enterprise Value Over EBITDA | (13.29) | (12.62) | |
| Price Book Value Ratio | 40.31 | 42.32 | |
| Enterprise Value Multiple | (13.29) | (12.62) | |
| Price Fair Value | 40.31 | 42.32 | |
| Enterprise Value | 566.1 M | 537.8 M |
Leadership effectiveness at Vincerx Pharma is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vincerx Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vincerx Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vincerx Pharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vincerx Pharma time-series forecasting models is one of many Vincerx Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vincerx Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Vincerx Pharma Earnings per Share Projection vs Actual
Vincerx Pharma Corporate Management
| Raj MBA | VP Manufacturing | Profile | |
| Melissa SPHR | Director Culture | Profile | |
| Karen Quarford | Vice Compliance | Profile | |
| Karen MBA | Vice Compliance | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.